HEADER TRANSCRIPTION/INHIBITOR 07-DEC-15 5F79 TITLE INFLUENZA PB2 BOUND TO AN AZAINDOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYMERASE BASIC PROTEIN 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: RNA-DIRECTED RNA POLYMERASE SUBUNIT P3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 3 ORGANISM_TAXID: 383596; SOURCE 4 STRAIN: A/BEIJING/39/1975 H3N2; SOURCE 5 GENE: PB2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B.1 KEYWDS SMALL MOLECULE INHIBITOR, POLYMERASE, TRANSCRIPTION-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.D.JACOBS REVDAT 3 27-SEP-23 5F79 1 REMARK REVDAT 2 01-MAR-17 5F79 1 JRNL REVDAT 1 07-DEC-16 5F79 0 JRNL AUTH U.K.BANDARAGE,M.P.CLARK,E.PEROLA,H.GAO,M.D.JACOBS,A.TSAI, JRNL AUTH 2 J.GILLESPIE,J.M.KENNEDY,F.MALTAIS,M.W.LEDEBOER,I.DAVIES, JRNL AUTH 3 W.GU,R.A.BYRN,K.NTI ADDAE,H.BENNETT,J.R.LEEMAN,S.M.JONES, JRNL AUTH 4 C.O'BRIEN,C.MEMMOTT,Y.BENNANI,P.S.CHARIFSON JRNL TITL NOVEL 2-SUBSTITUTED 7-AZAINDOLE AND 7-AZAINDAZOLE ANALOGUES JRNL TITL 2 AS POTENTIAL ANTIVIRAL AGENTS FOR THE TREATMENT OF JRNL TITL 3 INFLUENZA. JRNL REF ACS MED CHEM LETT V. 8 261 2017 JRNL REFN ISSN 1948-5875 JRNL PMID 28197323 JRNL DOI 10.1021/ACSMEDCHEMLETT.6B00487 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 8073 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 392 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.68 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2270 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1977 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2165 REMARK 3 BIN R VALUE (WORKING SET) : 0.1942 REMARK 3 BIN FREE R VALUE : 0.2697 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.63 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 105 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1280 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 51 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 61.47 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 68.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.40240 REMARK 3 B22 (A**2) : -4.40240 REMARK 3 B33 (A**2) : 8.80480 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.283 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.290 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.197 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.290 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.199 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1339 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 1799 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 505 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 31 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 219 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1339 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 174 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1530 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.16 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.16 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.45 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|21 - 114} REMARK 3 ORIGIN FOR THE GROUP (A): -41.8335 -1.2780 1.7131 REMARK 3 T TENSOR REMARK 3 T11: 0.0176 T22: -0.1518 REMARK 3 T33: -0.0935 T12: 0.0874 REMARK 3 T13: -0.0103 T23: -0.0052 REMARK 3 L TENSOR REMARK 3 L11: -0.0929 L22: 5.6055 REMARK 3 L33: 4.5090 L12: 0.7247 REMARK 3 L13: 1.2058 L23: 2.8374 REMARK 3 S TENSOR REMARK 3 S11: -0.0923 S12: 0.1010 S13: 0.0540 REMARK 3 S21: -0.6680 S22: -0.1212 S23: 0.4376 REMARK 3 S31: -0.3843 S32: -0.0583 S33: 0.2135 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {A|115 - 158} REMARK 3 ORIGIN FOR THE GROUP (A): -33.2267 -5.4184 5.8395 REMARK 3 T TENSOR REMARK 3 T11: 0.0110 T22: -0.2026 REMARK 3 T33: -0.1072 T12: 0.1890 REMARK 3 T13: 0.0528 T23: -0.0992 REMARK 3 L TENSOR REMARK 3 L11: 4.3549 L22: 15.4913 REMARK 3 L33: 7.6750 L12: -0.6913 REMARK 3 L13: 1.9024 L23: -1.2439 REMARK 3 S TENSOR REMARK 3 S11: -0.0970 S12: -0.0419 S13: -0.2850 REMARK 3 S21: 0.2692 S22: 0.2017 S23: -1.0461 REMARK 3 S31: 0.2006 S32: 0.6101 S33: -0.1047 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: {A|159 - 183} REMARK 3 ORIGIN FOR THE GROUP (A): -29.7903 12.0632 0.8966 REMARK 3 T TENSOR REMARK 3 T11: 0.1772 T22: -0.1810 REMARK 3 T33: -0.0823 T12: -0.1282 REMARK 3 T13: 0.2035 T23: -0.0276 REMARK 3 L TENSOR REMARK 3 L11: 2.5056 L22: 3.7819 REMARK 3 L33: 9.0324 L12: 3.9142 REMARK 3 L13: 2.7672 L23: 0.7717 REMARK 3 S TENSOR REMARK 3 S11: -0.0707 S12: 0.5493 S13: 0.1238 REMARK 3 S21: -1.2678 S22: 0.2435 S23: -0.9302 REMARK 3 S31: -0.8512 S32: 0.4181 S33: -0.1728 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5F79 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-DEC-15. REMARK 100 THE DEPOSITION ID IS D_1000216137. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9774 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.1 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9658 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.260 REMARK 200 RESOLUTION RANGE LOW (A) : 43.090 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.55800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 4NCE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 UL PROTEIN SOLUTION (2.8 MG/ML REMARK 280 PROTEIN, 50 MM TRIS, PH 8, 200 MM SODIUM CHLORIDE, 2 MM REMARK 280 DITHIOTHREITOL, 1 MM ANTHRAQUINONE-2,6-DISULFONIC ACID DISODIUM REMARK 280 SALT, 7.5 MM GTP) + 0.4 UL WELL SOLUTION (1.5 M SODIUM FORMATE, REMARK 280 100 MM SODIUM CITRATE, PH 4.7, 10 MM DITHIOTHREITOL) SUSPENDED REMARK 280 OVER 1 ML OF WELL SOLUTION, CRYSTALS TRANSFERRED TO A SOAKING REMARK 280 SOLUTION (3.25 M SODIUM FORMATE, 100 MM SODIUM CITRATE, PH 4.7) REMARK 280 CONTAINING 1 MM INHIBITOR, INCUBATED APPROXIMATELY 15 HOURS AT REMARK 280 ROOM TEMPERATURE, AND THEN TRANSFERRED TO A CRYO-PRESERVATIVE REMARK 280 SOLUTION (SOAKING SOLUTION WITH 25% V/V GLYCEROL) PRIOR TO REMARK 280 FREEZING IN LIQUID NITROGEN, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.41333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.20667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 27.31000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 9.10333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 45.51667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 15 REMARK 465 HIS A 16 REMARK 465 MET A 17 REMARK 465 ARG A 18 REMARK 465 ILE A 19 REMARK 465 SER A 20 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 41 CG CD OE1 OE2 REMARK 470 ARG A 136 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 118 -20.28 67.74 REMARK 500 ASP A 141 111.50 -161.44 REMARK 500 ASN A 156 -70.39 -59.44 REMARK 500 VAL A 157 84.28 13.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 4V7 A 4000 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4V7 A 4000 DBREF 5F79 A 18 183 UNP Q30NP1 PB2_I75A0 318 483 SEQADV 5F79 GLY A 15 UNP Q30NP1 EXPRESSION TAG SEQADV 5F79 HIS A 16 UNP Q30NP1 EXPRESSION TAG SEQADV 5F79 MET A 17 UNP Q30NP1 EXPRESSION TAG SEQADV 5F79 LYS A 89 UNP Q30NP1 ARG 389 CONFLICT SEQRES 1 A 169 GLY HIS MET ARG ILE SER SER SER PHE SER PHE GLY GLY SEQRES 2 A 169 PHE THR PHE LYS ARG THR SER GLY SER SER ILE LYS ARG SEQRES 3 A 169 GLU GLU GLU VAL LEU THR GLY ASN LEU GLN THR LEU LYS SEQRES 4 A 169 ILE ARG VAL HIS GLU GLY TYR GLU GLU PHE THR MET VAL SEQRES 5 A 169 GLY LYS ARG ALA THR ALA ILE LEU ARG LYS ALA THR ARG SEQRES 6 A 169 ARG LEU VAL GLN LEU ILE VAL SER GLY LYS ASP GLU GLN SEQRES 7 A 169 SER ILE ALA GLU ALA ILE ILE VAL ALA MET VAL PHE SER SEQRES 8 A 169 GLN GLU ASP CYS MET ILE LYS ALA VAL ARG GLY ASP LEU SEQRES 9 A 169 ASN PHE VAL ASN ARG ALA ASN GLN ARG LEU ASN PRO MET SEQRES 10 A 169 HIS GLN LEU LEU ARG HIS PHE GLN LYS ASP ALA LYS VAL SEQRES 11 A 169 LEU PHE GLN ASN TRP GLY ILE GLU HIS ILE ASP ASN VAL SEQRES 12 A 169 MET GLY MET VAL GLY VAL LEU PRO ASP MET THR PRO SER SEQRES 13 A 169 THR GLU MET SER MET ARG GLY ILE ARG VAL SER LYS MET HET 4V7 A4000 33 HETNAM 4V7 N-[(1R,3S)-3-({5-FLUORO-2-[5-FLUORO-2-(HYDROXYMETHYL)- HETNAM 2 4V7 1H-PYRROLO[2,3-B]PYRIDIN-3-YL]PYRIMIDIN-4-YL}AMINO) HETNAM 3 4V7 CYCLOHEXYL]PYRROLIDINE-1-CARBOXAMIDE FORMUL 2 4V7 C23 H27 F2 N7 O2 FORMUL 3 HOH *51(H2 O) HELIX 1 AA1 ASP A 90 SER A 105 1 16 HELIX 2 AA2 GLU A 107 ALA A 113 1 7 HELIX 3 AA3 ASN A 129 ASP A 141 1 13 HELIX 4 AA4 ALA A 142 GLY A 150 1 9 SHEET 1 AA1 8 SER A 22 PHE A 25 0 SHEET 2 AA1 8 PHE A 28 GLY A 35 -1 O PHE A 30 N PHE A 23 SHEET 3 AA1 8 GLU A 61 VAL A 66 -1 O VAL A 66 N THR A 29 SHEET 4 AA1 8 ALA A 70 ALA A 77 -1 O LYS A 76 N GLU A 61 SHEET 5 AA1 8 ARG A 80 GLY A 88 -1 O SER A 87 N THR A 71 SHEET 6 AA1 8 ILE A 178 SER A 181 1 O ARG A 179 N VAL A 86 SHEET 7 AA1 8 MET A 160 VAL A 163 -1 N VAL A 161 O VAL A 180 SHEET 8 AA1 8 PRO A 169 SER A 170 -1 O SER A 170 N GLY A 162 SHEET 1 AA2 2 ILE A 38 LEU A 45 0 SHEET 2 AA2 2 THR A 51 GLU A 58 -1 O ILE A 54 N GLU A 42 SHEET 1 AA3 2 ILE A 151 HIS A 153 0 SHEET 2 AA3 2 MET A 173 MET A 175 -1 O SER A 174 N GLU A 152 SITE 1 AC1 12 PHE A 23 PHE A 25 SER A 37 HIS A 57 SITE 2 AC1 12 GLU A 61 PHE A 63 LYS A 76 PHE A 104 SITE 3 AC1 12 GLN A 106 ASN A 129 MET A 131 HIS A 132 CRYST1 80.970 80.970 54.620 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012350 0.007130 0.000000 0.00000 SCALE2 0.000000 0.014261 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018308 0.00000